“The game, known as EndeavorRx and developed by Boston-based Akili Interactive Labs, can now be marketed as a way to improve attention function in kids with ADHD as measured by computerized testing. Physicians can prescribe it to children between the ages of 8 and 12 who have an ADHD diagnosis and have demonstrated an issue with attention.”
https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg
The FDA has given a green light for the first time to a game-based therapeutic: Akili’s video game EndeavorRx, designed to be prescribed to kids with ADHD.